The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.

Ítems similars

• The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
  per: Gardner, C. J., et al.
  Publicat: (1995)
• Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.
  per: Beresford, I. J., et al.
  Publicat: (1991)
• Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK(1) receptor antagonist
  per: Grélot, Laurent, et al.
  Publicat: (1998)
• Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK(1) and NK(3) receptors
  per: Malherbe, P, et al.
  Publicat: (2011)
• Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
  per: Maggi, C. A., et al.
  Publicat: (1990)